If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 43.50
Bid: 43.00
Ask: 44.00
Change: 0.00 (0.00%)
Spread: 1.00 (2.326%)
Open: 43.50
High: 43.50
Low: 43.50
Prev. Close: 43.50
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

8 Feb 2024 16:00

RNS Number : 5449C
Benchmark Holdings PLC
08 February 2024
 

8 February 2024

 

Benchmark Holdings plc

("Benchmark" or the "Company")

Result of AGM

Benchmark Holdings plc, the aquaculture health, nutrition and genetics business, announces that at the Company's Annual General Meeting, held at 12.00 midday today, all resolutions were passed by shareholders voting on a poll. The results of the poll are set out below.

 

 

RESOLUTION NAME

VOTESFOR

%

VOTESAGAINST

%

VOTESTOTAL

% of ISC VOTED

VOTESWITHHELD

1

Report and accounts

645,672,343

100.00

0

0.00

645,672,343

87.31%

0

2

Remuneration Report

612,982,715

94.94

32,689,628

5.06

645,672,343

87.31%

0

3

Reappoint Auditors

643,743,477

99.70

1,928,866

0.30

645,672,343

87.31%

0

4

Auditors remuneration

645,610,137

99.99

58,456

0.01

645,668,593

87.31%

3,750

5

Trond Williksen

645,606,455

99.99

65,888

0.01

645,672,343

87.31%

0

6

Kristian Eikre

613,627,401

95.04

32,044,942

4.96

645,672,343

87.31%

0

7

Septima Maguire

645,623,216

99.99

49,127

0.01

645,672,343

87.31%

0

8

Peter George

622,043,212

96.34

23,629,131

3.66

645,672,343

87.31%

0

9

Yngve Myhre

645,611,387

99.99

60,956

0.01

645,672,343

87.31%

0

10

Jonathan Esfandi

643,783,409

99.71

1,888,934

0.29

645,672,343

87.31%

0

11

Torgeir Svae

643,780,909

99.71

1,891,434

0.29

645,672,343

87.31%

0

12

Marie Danielsson

643,783,409

99.71

1,888,934

0.29

645,672,343

87.31%

0

13

Allot shares

624,578,624

96.73

21,081,451

3.27

645,660,075

87.31%

12,268

14

Disapply pre-emption rights

645,600,998

99.99

59,077

0.01

645,660,075

87.31%

12,268

15

Disapply additional pre-emption rights

643,739,328

99.70

1,920,747

0.30

645,660,075

87.31%

12,268

16

Purchase own shares

643,743,231

99.70

1,929,112

0.30

645,672,343

87.31%

0

 

Enquiries

 

For further information, please contact:

Benchmark Holdings plc

benchmark@mhpc.com

Ivonne Cantu, Investor Relations

Deutsche Numis (Broker and NOMAD)

Tel: 020 7260 1000

Freddie Barnfield / Duncan MonteithSher Shah

MHP

Tel: +44 (0) 20 3128 8100

Katie Hunt, Reg Hoare

benchmark@mhpgroup.com

 

 

About Benchmark

Benchmark is a market leading aquaculture biotechnology company. Benchmark's mission is to drive sustainability in aquaculture by delivering mission-critical products and solutions in genetics, advanced nutrition and health which improve yield, growth and animal health and welfare. Through a global footprint in 26 countries and a broad portfolio of products and solutions, Benchmark addresses the major aquaculture species - salmon, shrimp, sea bass and bream, and tilapia, in all the aquaculture regions around the world.

Find out more at www.benchmarkplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUWOVRSWUURAR
Date   Source Headline
7th Dec 20183:35 pmRNSHolding(s) in Company
30th Nov 20187:00 amRNSTotal Voting Rights
30th Nov 20187:00 amRNSTotal Voting Rights
27th Nov 20187:00 amRNSSuccessful defence of patent infringement in Asia
7th Nov 20187:00 amRNSTrading Statement
31st Oct 20187:00 amRNSTotal Voting Rights
23rd Oct 20184:55 pmRNSHolding(s) in Company
22nd Oct 20185:52 pmRNSHolding(s) in Company
10th Oct 20182:53 pmRNSDIRECTOR DEALINGS
3rd Oct 20187:00 amRNSAcquisition and Issue of Equity
2nd Oct 20187:00 amRNSAppointment of Chief Scientific Officer
28th Sep 20187:00 amRNSTotal Voting Rights
21st Sep 20187:00 amRNSBlock listing Interim Review
12th Sep 20187:00 amRNSBlock Admission Application
10th Sep 20187:00 amRNSCommencement of salmon egg production in Salten
30th Aug 20187:00 amRNSTotal Voting Rights
30th Jul 20187:00 amRNSTotal Voting Rights
2nd Jul 20187:00 amRNSAppointment of Executive Director
29th Jun 20187:00 amRNSTotal Voting Rights
27th Jun 20184:36 pmRNSHolding(s) in Company
25th Jun 20184:01 pmRNSHolding(s) in Company
22nd Jun 20184:31 pmRNSHolding(s) in Company
22nd Jun 20187:00 amRNSDIRECTOR DEALINGS
19th Jun 20184:06 pmRNSUpdate on Joint Venture and Placing
19th Jun 20187:00 amRNSInterim Results
8th Jun 20187:00 amRNSJoint Venture, Placing and Trading Update
31st May 20187:00 amRNSTotal Voting Rights
8th May 20187:00 amRNSAppointment of Chairman
30th Apr 201812:23 pmRNSTotal Voting Rights
9th Apr 201811:14 amRNSHolding(s) in Company
5th Apr 20183:58 pmRNSHolding(s) in Company
3rd Apr 20187:00 amRNSTotal Voting Rights
27th Mar 20187:00 amRNSBenchmark hosts Capital Markets Day today
21st Mar 20187:00 amRNSBlock listing six monthly return
8th Mar 20181:37 pmRNSResult of AGM
7th Feb 20189:05 amRNSDirector Dealings
31st Jan 20187:00 amRNSBoard Succession
31st Jan 20187:00 amRNSTotal Voting Rights
25th Jan 201811:54 amRNSDirector Share Options
24th Jan 20183:17 pmRNSHolding(s) in Company
24th Jan 20181:01 pmRNSDirector Dealings
24th Jan 20187:00 amRNSPosting of Annual Report & Notice of AGM
23rd Jan 20187:08 amRNSFinal Results
19th Jan 20184:40 pmRNSSecond Price Monitoring Extn
19th Jan 20184:35 pmRNSPrice Monitoring Extension
5th Jan 20184:19 pmRNSHolding(s) in Company
4th Jan 20184:41 pmRNSSecond Price Monitoring Extn
4th Jan 20184:35 pmRNSPrice Monitoring Extension
12th Dec 20177:00 amRNSCommercial scale field trial of sea lice treatment
7th Dec 20177:00 amRNSBenchmark participates in gene editing research

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.